X0306 4 2018-03-01 0 0001444380 NEVRO CORP NVRO 0001417976 Galligan Andrew H C/O NEVRO CORP. 1800 BRIDGEWAY PARKWAY REDWOOD CITY CA 94065 0 1 0 0 Chief Financial Officer Common Stock 2018-03-01 4 M 0 7000 18.00 A 35192 D Common Stock 2018-03-01 4 S 0 5540 79.8999 D 29652 D Common Stock 2018-03-01 4 S 0 1460 80.867 D 28192 D Stock Option (Right to Buy) 18.00 2018-03-01 4 M 0 7000 0.00 D 2024-11-04 Common Stock 7000 28463 D Includes 18,125 restricted stock units. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $79.39 to $80.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $80.45 to $81.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. /s/ Andrew Galligan 2018-03-05